RT Journal Article
SR Electronic
T1 Initial Experience with Oral Contrast in PET/CT: Phantom and Clinical Studies
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 412
OP 416
VO 44
IS 3
A1 Cohade, Christian
A1 Osman, Medhat
A1 Nakamoto, Yuji
A1 Marshall, Laura T.
A1 Links, Jonathan M.
A1 Fishman, Elliot K.
A1 Wahl, Richard L.
YR 2003
UL http://jnm.snmjournals.org/content/44/3/412.abstract
AB The aims of the study were to evaluate the effects of oral contrast on apparent tracer activity measured with PET/CT when using CT attenuation correction and to report our initial experience in the use of oral contrast with PET/CT. Methods: Phantom studies with 18F activity and saline bags or syringes filled with barium or gastrografin of varying densities were performed using a PET/CT scanner (CT attenuation correction). In the study, 91 clinical patients received dilute oral contrast and were evaluated by whole-body 18F-FDG PET. Results: A phantom experiment with CT contrast (1.3% weight/volume [w/v] barium) showed a “cold” area in the cold stomach whereas a phantom with high-density barium (98% w/v) showed an artifactual focus of intense “activity” in the cold stomach. In clinical studies, stomach and right colon were opacified by CT contrast. Maximal measured contrast density was 239 Hounsfield units. Conclusion: High-density barium causes overestimation of tissue 18F-FDG concentration. Low-density barium does not cause significant artifacts and appears suitable for clinical use.